Carboplatin and cisplatin: are they equivalent in efficacy in "optimal residual" advanced ovarian cancer?

Markman, M

Carboplatin and cisplatin: are they equivalent in efficacy in "optimal residual" advanced ovarian cancer? [electronic resource] - Journal of cancer research and clinical oncology 1996 - 443-4 p. digital

Publication Type: Editorial

0171-5216

10.1007/BF01187154 doi


Antineoplastic Agents--therapeutic use
Carboplatin--therapeutic use
Cisplatin--therapeutic use
Female
Humans
Ovarian Neoplasms--drug therapy